Cargando…

Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics

IMPORTANCE: US primary care practitioners (PCPs) are the largest clinical workforce, but few provide addiction care. Primary care is a practical place to expand addiction services, including buprenorphine and harm reduction kits, yet the clinical outcomes and health care sector costs are unknown. OB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jawa, Raagini, Tin, Yjuliana, Nall, Samantha, Calcaterra, Susan L., Savinkina, Alexandra, Marks, Laura R., Kimmel, Simeon D., Linas, Benjamin P., Barocas, Joshua A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098970/ https://www.ncbi.nlm.nih.gov/pubmed/37043198 http://dx.doi.org/10.1001/jamanetworkopen.2023.7888

Ejemplares similares

Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use–Associated Infective Endocarditis
por: Adams, Joëlla W., et al.
Publicado: (2022)

Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study
por: Barocas, Joshua A, et al.
Publicado: (2022)

58. Cost-Effectiveness of Emerging Antibiotic Strategies for the Treatment of Drug-Use Associated Infective Endocarditis
por: Adams, Joella W, et al.
Publicado: (2021)

Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities
por: Kimmel, Simeon D., et al.
Publicado: (2020)

1549. Association of Skin Infections with Sharing of Injection Drug Preparation Equipment among People who Inject Drugs
por: Jawa, Raagini, et al.
Publicado: (2020)

Behavioral Risk Factors for HIV Infection in Hospitalized Persons Who Co-use Stimulants and Opioids
por: Jawa, Raagini, et al.
Publicado: (2021)

Implementing harm reduction kits in an office-based addiction treatment program
por: Shang, Margaret, et al.
Publicado: (2023)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
por: Chatterjee, Avik, et al.
Publicado: (2023)

Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics: A Randomized Clinical Trial
por: Edelman, E. Jennifer, et al.
Publicado: (2022)

Projected Estimates of Opioid Mortality After Community-Level Interventions
por: Linas, Benjamin P., et al.
Publicado: (2021)

Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use–Associated Infective Endocarditis
por: Kimmel, Simeon D., et al.
Publicado: (2020)

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting
por: Morgan, Jake R., et al.
Publicado: (2020)

Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations
por: Miller-Rosales, Chris, et al.
Publicado: (2023)

Nicotine Addiction and Intensity of e-Cigarette Use by Adolescents in the US, 2014 to 2021
por: Glantz, Stanton, et al.
Publicado: (2022)

Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use
por: Corace, Kim, et al.
Publicado: (2023)

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019)

Rapid Naloxone Administration Workshop for Health Care Providers at an Academic Medical Center
por: Jawa, Raagini, et al.
Publicado: (2020)

2002. Infectious Diseases fellowship training on caring for people who use drugs: A national survey-based needs assessment
por: Vasishta, Shilpa, et al.
Publicado: (2023)

Incidence and Characteristics of Nonfatal Opioid Overdose Among Youths Aged 11 to 24 Years by Sex
por: Bagley, Sarah M., et al.
Publicado: (2020)

Identifying Conditions With High Prevalence, Cost, and Variation in Cost in US Children’s Hospitals
por: Gill, Peter J., et al.
Publicado: (2021)

Model-Estimated Association Between Simulated US Elementary School–Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels
por: Giardina, John, et al.
Publicado: (2022)

Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases
por: Toumi, Asmae, et al.
Publicado: (2021)

The Cost of Provisions
Publicado: (1905)

The Cost of Provisions
Publicado: (1894)

Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule
por: Kong, Edward, et al.
Publicado: (2023)

Tobacco Use, Nicotine Dependence, and Cessation Methods in US Adults With Psychosis
por: Han, Beth, et al.
Publicado: (2023)

Assessment of Annual Cost of Substance Use Disorder in US Hospitals
por: Peterson, Cora, et al.
Publicado: (2021)

Cost of Public Health Insurance for US-Born and Immigrant Adults
por: Kaushal, Neeraj, et al.
Publicado: (2023)

Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
por: Barocas, Joshua A, et al.
Publicado: (2021)

Predictive Genomic Analyses Inform the Basis for Vitamin Metabolism and Provisioning in Bacteria-Arthropod Endosymbioses
por: Serbus, Laura R., et al.
Publicado: (2017)

Rethinking Home-based Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Drugs: An Opportunity for Change in the Time of COVID-19
por: Jawa, Raagini, et al.
Publicado: (2022)

Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults
por: Nabi, Junaid, et al.
Publicado: (2020)

Estimated Cost of Developing a Therapeutic Complex Medical Device in the US
por: Sertkaya, Aylin, et al.
Publicado: (2022)

Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US
por: Wang, Yehua, et al.
Publicado: (2023)

Micro-costing the provision of emotional support and information in UK eye clinics
por: Gillespie-Gallery, Hanna, et al.
Publicado: (2013)

Cost of Provisions in Hospitals
Publicado: (1906)

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
por: Bennett, Tellen D., et al.
Publicado: (2021)

Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US
por: Bhattacharya, Kaustuv, et al.
Publicado: (2021)

Hospital Costs and Fatality Rates of Traumatic Assaults by Mechanism in the US, 2016-2018
por: Barry, Luke E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jvg43rc4qljnnocuva4pt6tsjq